Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress

Carvedilol attenuates carbon tetrachloride-induced liver fibrosis and hepatic sinusoidal capillarization in mice

(2019) Ying Wu et al.   Drug Design Development and Therapy

Nilotinib enhances β-islets integrity and secretory functions in a rat model of STZ-induced diabetes mellitus

(2019) Mahmoud M. Samaha et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice

(2019) Keyvan Amirshahrokhi   INTERNATIONAL IMMUNOPHARMACOLOGY

The proinflammatory effects of macrophage-derived NADPH oxidase function in autoimmune diabetes

(2018) Joseph M. Feduska et al.   FREE RADICAL BIOLOGY AND MEDICINE

Withaferin-A attenuates multiple low doses of Streptozotocin (MLD-STZ) induced type 1 diabetes

(2018) Sravani Tekula et al.   BIOMEDICINE & PHARMACOTHERAPY

Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats

(2018) Hebatollah E. Eitah et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Methylsulfonylmethane is effective against gastric mucosal injury

(2017) Keyvan Amirshahrokhi et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling

(2017) Bethany A. Carboneau et al.   Journal of Cell Communication and Signaling

Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-κB activation and oxidative stress mediators

(2016) Keyvan Amirshahrokhi et al.   CYTOKINE

Gastroprotective effect of 2-mercaptoethane sulfonate against acute gastric mucosal damage induced by ethanol

(2016) Keyvan Amirshahrokhi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Neutrophils in type 1 diabetes

(2016) Juan Huang et al.   Journal of Diabetes Investigation

Anti-oxidative effect of theβ-blocker carvedilol on diabetic nephropathy in non-obese type 2 diabetic rats

(2015) Yuriko Yonekura et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice

(2014) Antonio Citro et al.   DIABETES

Macrophages and  -cells are responsible for CXCR2-mediated neutrophil infiltration of the pancreas during autoimmune diabetes

(2014) J. Diana et al.   EMBO Molecular Medicine

Role of NF-κB in the pathogenesis of diabetes and its associated complications

(2014) Sandip Patel et al.   Pharmacological Reports

Thalidomide attenuates multiple low-dose streptozotocin-induced diabetes in mice by inhibition of proinflammatory cytokines

(2012) K. Amirshahrokhi et al.   CYTOKINE

New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage

(2012) Nadia Hamdy et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Diabetogenic T lymphocytes in human Type 1 diabetes

(2011) Bart O Roep et al.   CURRENT OPINION IN IMMUNOLOGY

IL-17 Immunity in Human Type 1 Diabetes

(2010) J. Honkanen et al.   JOURNAL OF IMMUNOLOGY

Anti-hyperglycemic, antioxidant and anti-inflammatory effects of VIP and a VPAC1 agonist on streptozotocin-induced diabetic mice

(2010) Rongjie Yu et al.   PEPTIDES

Oxidative stress: the vulnerable β-cell

(2008) Sigurd Lenzen   BIOCHEMICAL SOCIETY TRANSACTIONS

NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes

(2008) Hisafumi Yasuda et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Interaction between pro-inflammatory and anti-inflammatory cytokines in insulin-producing cells

(2008) Kleber L A Souza et al.   JOURNAL OF ENDOCRINOLOGY